Codexis (CDXS) and Nitto Denko (NDEKY) Avecia (NDEKY0 announced that they have entered into an evaluation agreement. Under the terms of the agreement, Nitto Denko Avecia will evaluate Codexis’ ECO Synthesis Manufacturing Platform. The collaboration will pave the way for licensing discussions and broader adoption of the ECO Synthesis platform, which replaces traditional solid-phase oligonucleotide synthesis with a flexible, enzyme-catalyzed approach built to scale.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDXS: